Navigation Links
Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
Date:2/22/2010

SAN DIEGO and OSAKA, Japan, Feb. 22, 2010 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Takeda Pharmaceutical Company Limited (TSE: 4502) announced today that the companies have selected the combination treatment of pramlintide, an analog of the natural hormone amylin, and metreleptin, an analog of the natural hormone leptin, for advancement toward Phase 3 development. The decision to advance the program followed encouraging results from a 52-week blinded, placebo-controlled Phase 2 extension study. The pramlintide/metreleptin combination met the key target criteria of sustained and robust weight loss.

"There i
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Amylin Pharmaceuticals to Webcast Year-End Financial Results
2. Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
3. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
4. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
5. Amylin Pharmaceuticals Reports Third Quarter Financial Results
6. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
7. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
8. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
9. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
10. Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate)
11. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... and DUBLIN , ... TNIB) ("we" or the "Company"), a biotechnology company ... for autoimmune diseases in emerging nations, today announced ... our common stock for DTC,s Deposit and Withdrawal ... Securities Transfer Service ("FAST") transfer agent as the ...
(Date:9/23/2014)... 23, 2014 Research and Markets  has announced ... report to their offering. Diabetes is ... globe. Over 382 million people are estimated to be currently ... to 592 million by 2035. With a very high ... and India , an increasing ...
(Date:9/23/2014)... -- The Pennsylvania State Police will accept unwanted, expired and ... National Prescription Drug Take-Back Day. The service is free ... is a national initiative, conducted in partnership with the ... public to dispose of expired, unused or unwanted prescription ... From 10 a.m. to 2 p.m., unwanted prescription ...
Breaking Medicine Technology:TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 3TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 4Glycated Haemoglobin (HbA1c) Testing Market 2Glycated Haemoglobin (HbA1c) Testing Market 3
... Techne Corporation,s (NASDAQ: TECH ) financial results for ... First quarter earnings were $27.5 million or $.74 ... to $30.0 million or $.81 per diluted share after adjustment ... of inventory that was written-up to fair value as part ...
... PAREXEL International Corporation (NASDAQ: PRXL ... today announced that the Company has expanded ... dedicated support for their commercialization goals ... services to help clients maximize regional and global ...
Cached Medicine Technology:Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 2Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 3Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 4Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 5Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 6Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 7Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 8PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value 2PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value 3PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value 4PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value 5
(Date:9/23/2014)... Ore. A recent Oregon survey about an exercise ... the daily routine of elementary school students found it ... and teachers, and offered clear advantages for overly sedentary ... developed and produced by the Healthy Youth Program of ... is available nationally. , Brain Breaks leads children in ...
(Date:9/23/2014)... national report showing the benefits of preventing a ... Medicaid services was released today by the American ... Congress Must Save the Medicaid Primary Care Pay ... Access to Life-Saving Primary Care Will Expire," explains ... access to internists and pediatricians (and their related ...
(Date:9/23/2014)... Vancouver Electrician Contractors, Pro Ace, has recently announced ... in Vancouver, BC. The company will provide services on ... maintenance project or a large-scale new installation project, Pro ... needs of the individual commercial client. Pro Ace has ... affordable price. As a result, businesses of all sizes ...
(Date:9/23/2014)... September 23, 2014 The ... rhinitis (AR) is highly fragmented, with the ... formulations available, under different regulatory restrictions, with ... Europe has the most developed market, with ... allergen immunotherapy tablets (AITs) all being available. ...
(Date:9/23/2014)... SOURCE: Solutions from Our Country’s Entrepreneurs ... Rimidi Diabetes and TruClinic (TM) ... to challenges faced by patients and healthcare systems. ... The Hitachi Foundation, Village Capital, and ... investment capital, mentoring, and support needed to grow their ...
Breaking Medicine News(10 mins):Health News:'Brain Breaks' increase activity, educational performance in elementary schools 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 3Health News:Unless Congress acts, patients may soon lose access to primary care 2Health News:Unless Congress acts, patients may soon lose access to primary care 3Health News:Pro Ace Now Offers Commercial Electrical Services in Vancouver 2Health News:Allergen extract Allergic Rhinitis Specific Immunotherapy Market to Grow $688.3m by 2018 Says a New Report Available at MarketOptimizer.org 2Health News:Allergen extract Allergic Rhinitis Specific Immunotherapy Market to Grow $688.3m by 2018 Says a New Report Available at MarketOptimizer.org 3Health News:Allergen extract Allergic Rhinitis Specific Immunotherapy Market to Grow $688.3m by 2018 Says a New Report Available at MarketOptimizer.org 4Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 2Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 3Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 4Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 5
... ... Island man,s sense of smell and taste , ... Mineola, N.Y.(Lexis Nexis) July 8, 2009 -- Marc Grossman , senior ... N.Y., today announced that his firm has filed a civil lawsuit against the manufacturer of ...
... -- Perot Systems Corporation (NYSE: PER ) ... a Chinese-language website as part of the company,s expanded presence ... , , "Perot Systems is in the early stages ... for the reception we have received from local leaders across ...
... Chairman of the U.S. Catholic Bishops, Committee on Pro-Life ... stem cell research issued yesterday by the National Institutes ... , , "In April I criticized the NIH,s ... that under these guidelines ,federal tax dollars will be ...
... -- Chemical dependency and recovery in patients and physicians ... editorials in the July 2009 issue of Mayo ... the immense challenges, including potential tragedies, of prescription chemical ... crucial overview, direction and optimism. Addiction to ...
... July 7 DRINKiQ.com , Diageo,s ... Communicator Award as the Most Outstanding Health and Wellness web ... The site was also named runner-up in the Education Category. ... honors creative excellence for communications professionals. The program is sanctioned ...
... 7 AMB Property Corporation(R) (NYSE: AMB ), ... today announced that it has fully leased a 328,000 square ... in Hamburg to BSN medical GmbH, a leading global medical ... BSN medical,s previous commitment to 210,000 square feet (19,500 square ...
Cached Medicine News:Health News:New York Law Firm Files Lawsuit Against Manufacturer of Zicam Nasal Spray and Drugstore Chain That Sold Product 2Health News:Perot Systems Launches Website in Chinese to Support Expansion Into China 2Health News:Cardinal Rigali Criticizes Final NIH Guidelines for Destructive Stem Cell Research 2Health News:A comprehensive review of addiction to prescription painkillers among patients and physicians 2Health News:A comprehensive review of addiction to prescription painkillers among patients and physicians 3Health News:Diageo's DRINKiQ.com Honored as Most Outstanding Health & Wellness Site by International Academy of the Visual Arts 2Health News:Diageo's DRINKiQ.com Honored as Most Outstanding Health & Wellness Site by International Academy of the Visual Arts 3Health News:AMB Property Corporation(R) Leases 440,000 SF in Hamburg 2Health News:AMB Property Corporation(R) Leases 440,000 SF in Hamburg 3Health News:AMB Property Corporation(R) Leases 440,000 SF in Hamburg 4
... Verisyse Phakic IOL is used to ... medical term for nearsightedness. With over ... procedures performed worldwide, results prove that ... effective for very nearsighted people who ...
... CELL-DYN 3200 sets a benchmark of ... scatter for WBC, RBC, PLT and ... the needs of today's laboratory. The ... differential analysis, automated sample handling, comprehensive ...
The Mini Vidas is a compact version of the Vidas system with a built-in computer, keyboard and printer. Two independent sections each accept six tests and can process up to 12 samples simultaneously....
Inquire...
Medicine Products: